title: Propranolol treatment for infantile hemangioma does not increase risk of childhood wheezing.
abstract: Propranolol is the treatment of choice for infantile hemangiomas requiring medical intervention. Although contraindicated in asthma, its bronchoconstrictive effect in infants and children has not been extensively studied. We aimed to assess the incidence of wheezing episodes in infants and children treated with propranolol for infantile hemangiomas.
  
  
  
  A retrospective case-control study.
  
  
  
  a tertiary pediatric hospital.
  
  
  
  All Children followed for infantile hemangioma between 2009 and 2014. Children followed conservatively served as control group and were matched 1:1 for gender and month of birth by random matching to children treated with propranolol.
  
  
  
  All respiratory episodes (asthma, wheezing, stridor, and pneumonia) and respiratory associated hospitalizations were recorded from hospital records, from the primary care physician visits records and pharmacy prescriptions. The main outcome measure was the incidence of respiratory episodes in the treatment and the control groups.
  
  
  
  A total of 1828 clinic visits were reviewed for 683 children. In addition, primary care physician visits records were available in 80% of them. Two hundred and sixteen children were treated with propranolol. Incidence of respiratory episodes and recurrent respiratory episodes was similar in the propranolol and control groups (8.3% vs 12%, P = 0.265; 3.7% vs 6.5%, P = 0.274, respectively). Time to first episode was similar in the treatment and control groups (5.03 ± 3.32 vs 4.45 ± 3.21 months, respectively, P = 0.09). Respiratory hospital admission rate was similar in both groups.
  
  
  
  Propranolol treatment does not exacerbate wheezing episodes in infants and children.
authors.affiliation: Kathy and Lee Graub Cystic Fibrosis Center Pulmonary Institute, Schneider Children's Medical Center, Petach Tikva, Israel.|Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: Meir
authors.identifier: 0000-0002-6683-0264
authors.initials: M
authors.lastname: Mei-Zahav
authors.affiliation: Kathy and Lee Graub Cystic Fibrosis Center Pulmonary Institute, Schneider Children's Medical Center, Petach Tikva, Israel.|Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: Hannah
authors.initials: H
authors.lastname: Blau
authors.affiliation: Clalit Research Institute, Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.
authors.forename: Moshe
authors.initials: M
authors.lastname: Hoshen
authors.affiliation: Pediatric Dermatology Unit, Schneider Children's Medical Center, Petach Tikva, Israel.|Faculty of Health Sciences, Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
authors.forename: Alex
authors.initials: A
authors.lastname: Zvulunov
authors.affiliation: Kathy and Lee Graub Cystic Fibrosis Center Pulmonary Institute, Schneider Children's Medical Center, Petach Tikva, Israel.|Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: Huda
authors.initials: H
authors.lastname: Mussaffi
authors.affiliation: Kathy and Lee Graub Cystic Fibrosis Center Pulmonary Institute, Schneider Children's Medical Center, Petach Tikva, Israel.|Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: Dario
authors.initials: D
authors.lastname: Prais
authors.affiliation: Kathy and Lee Graub Cystic Fibrosis Center Pulmonary Institute, Schneider Children's Medical Center, Petach Tikva, Israel.|Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: Patrick
authors.identifier: 0000-0001-8880-8212
authors.initials: P
authors.lastname: Stafler
authors.affiliation: Kathy and Lee Graub Cystic Fibrosis Center Pulmonary Institute, Schneider Children's Medical Center, Petach Tikva, Israel.|Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: Guy
authors.initials: G
authors.lastname: Steuer
authors.affiliation: Sackler School of Medicine, Tel Aviv University, Israel.|Laser Unit, Department of Dermatology, Rabin Medical Center, Petah Tikva, Israel.
authors.forename: Moshe
authors.initials: M
authors.lastname: Lapidoth
authors.affiliation: Sackler School of Medicine, Tel Aviv University, Israel.|Pediatric Dermatology Unit, Schneider Children's Medical Center, Petach Tikva, Israel.
authors.forename: Dan Ben
authors.initials: DB
authors.lastname: Amitai
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001249:Asthma / Q000453:epidemiology; D016022:Case-Control Studies; D002675:Child, Preschool; D005260:Female; D006391:Hemangioma / Q000188:drug therapy* / Q000453:epidemiology; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D011014:Pneumonia / Q000453:epidemiology; D011433:Propranolol / Q000627:therapeutic use*; D012135:Respiratory Sounds / Q000209:etiology*; D012189:Retrospective Studies; D012306:Risk; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol
keywords: asthma; early wheeze; hemangioma; propranolol